NCT00909337View on ClinicalTrials.gov

Early Therapy of Pulmonary Arterial Hypertension

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Pulmonary HypertensionSystemic Sclerosis
Interventions
DRUG

Bosentan

2x62.5mg for 4 weeks, then 2x125mg

Trial Locations (1)

8036

Medical University of Graz, Pulmonology, Graz

Sponsors

Collaborators (1)

Actelion
All Listed Sponsors
collaborator

Actelion

INDUSTRY

lead

Medical University of Graz

OTHER

NCT00909337 - Early Therapy of Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter